It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 4, 2002, Pages 378-387

  Contag, Christopher H ^a,c   Ross, Brian D ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Gene expression; Luciferase; Molecular imaging; MRI

Indexed keywords

DNA; ETOPOSIDE; FLUCYTOSINE; FLUOROURACIL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; INTEIN; INTERLEUKIN 12; LUCIFERASE; MYELIN BASIC PROTEIN; MYOD PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 6;

ADOPTIVE IMMUNOTHERAPY; ALLERGIC ENCEPHALOMYELITIS; BIOLUMINESCENCE; BONE MARROW METASTASIS; BONE METASTASIS; BREAST CARCINOMA; CELL POPULATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GLIOMA; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; RADIOGRAPHY; REPORTER GENE; REVIEW; TRANSCRIPTION REGULATION; TUMOR MODEL; VALIDATION PROCESS;

ANIMALS; GENE THERAPY; LUCIFERASES; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, EXPERIMENTAL; OPTICS; RADIOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036793192     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10178     Document Type: Review

References (92)

1. Hoffman JM. Imaging in cancer: a National Cancer Institute "extraordinary opportunity". Neoplasia 2000;2:5-8.
2. Rehemtulla A, Hall DE, Stegmanet LD, et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Molec Imaging 2002;1:43-55.
3. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001;7:743-748.
4. Chinnaiyan AM, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A 2000;97:1754-1759.
5. Rehemtulla A, Stegman LD, Cardozo SJ, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000;2:491-495.
6. Evelhoch JL, Gillies RJ, Karczmar GS, et al. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia 2000;2:152-165.
7. Kurhanewicz J, Vigneron DB, Nelson SJ. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2000;2:166-189.
8. Kaplan O, Firon M, Vivi A, Navon G, Tsarfaty I, et al. HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells. Neoplasia 2000;2:365-377.
9. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001;3:489-499.
10. Bogdanov A, Matuszewski L, Bremer C, Petrovsky A, Weissleder R. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Molec Imaging 2002;1:16-23.
11. Hogemann D, Josephson L, Weissleder R, Basilion JP. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 2000;11:941-946.
12. Gillies RJ, Bhujwalla ZM, Evelhoch J. et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000;2:139-151.
13. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solalyappan M. Vascular differences detected by MRI for metastatic versus non-metastatic breast and prostate cancer xenografts. Neoplasia 2001;3:143-153.
14. Pilatus U, Ackerstaff E, Artemov D, Mori N, Gillies RJ, Bhujwalla ZM. Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber. Neoplasia 2000;2:273-279.
15. Chenevert TL, Stegman LD, Taylor JM. Robertson PL, Greenberg HS, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
16. Stegman LD, Rehemtulla A, Beattie B, et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1999;96:9821-9826.
17. Ponomarev V, Doubrovin M, Lyddane C, et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 2001;3:480-488.
18. Gambhir SS, Herschman HR, Cherry SR, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000;2:118-138.
19. Tjuvajev JG, Joshi A, Callegari J, et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1999;1:315-320.
20. Gambhir SS, Barrio JR, Wu L, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A 1999;96:2333-2338.
21. Mankoff DA, Dehdashtiand F, Shields AF. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia 2000;2:71-88.
22. Dyszlewski M, Blake HM, Dahlheimer JL, Pica CM, Piwnica-Worms D. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity. Molec Imaging 2002;1:24-36.
23. Hackman T, Doubrovin M, Balatoni J, et al. Imaging expression of cytosine deaminase - herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Molec Imaging 2002;1:36-42.
24. Hay RV, Cao B, Skinner RS, et al. Radioimmunoscintigraphy of tumors autocrine for human Met and hepatocyte growth factor/ scatter factor. Molec Imaging 2002;1:56-62.
25. Burt BM, Humm JL, Kooby DA, et al. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia 2001;3:189-195.
26. Kristensen CA, Hamberg LM, Hunter GJ, et al. Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy. Neoplasia 1999;1:518-525.
27. Paulus MJ, Gleason SS, Kennel SJ, Hunsicker PR, Johnson DK. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2000;2:62-70.
28. Sameni M, Moin K, Sloane BF. Imaging proteolysis by living human breast cancer cells. Neoplasia 2000;2:496-504.
29. Jacobs A, Dubrovin M, Hewett J, et al. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1999;1:154-161.
30. Fujimoto JG, Pitris C, Boppart SA, Brezinski ME. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia 2000;2:9-25.
31. Tromberg BJ, Shah N, Lanning R, et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000;2:26-40.
32. Vajkoczy P, Ullrich A, Menger MD. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2000;2:53-61.
33. Ramanujam N. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2000;2:89-117.
34. Pedersen MW, Holm S, Lund EL, Hojgaard L, Kristjansen PE. Co-regulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 2001;3:80-87.
35. Kragh M, Quistorff B, Lund EL, Kristjansen PE. Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy. Neoplasia 2001;3;324-330.
36. Vordermark D, Shibata T, Brown JM. Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation. Neoplasia 2001;3:527-534.
37. Edinger M, Sweeney TJ, Tucker AA, Olomu AB. Negrin RS, Contag CH. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999;1:303-310.
38. Contag CH, Jenkins D, Contag PR, Negrin RS. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000;2:41-52.
39. Padera TP, Stoll BR, So PTC, Jain RK. Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Molec Imaging 2002;1:9-15.
40. Hawrysz DJ, Sevick-Muraca EM. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2000;2:388-417.
41. Chishima T, Yang M, Miyagi Y, et al. Governing step of metastasis visualized in vitro, Proc Natl Acad Sci U S A 1997;94:11573-11576.
42. Hoffman RM. Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev 1998;17:271-277.
43. Sweeney TJ, Mailander V. Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 1999;96:12044-12049.
44. Yang M, Baranov E, Jiang P, et al. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A 2000;97:1206-1211.
45. Colin M, Moritz S, Schneider H, Capeau J, Coutelle C, Brahimi-Horn MC. Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo. Gene Ther 2000;7:1333-1336.
46. Reynier P, Lesage D, Cao A, Briane D, Coudert R, Taillandier E. A simple method to overcome the interference of hemoglobin in the detection of reporter genes in vivo. Anal Biochem 2002;301:217-224.
47. Smith AD, Trempe JP. Luminometric quantitation of photinus pyralis firefly luciferase and Escherichia coli beta-galactosidase in blood-contaminated organ lysates. Anal Biochem 2000;286:164-172.
48. Benaron DA, Cheongand WF, Stevenson DK. Tissue optics. Science 1997;276:2002-2003.
49. Cheong WF, Prahl SA, Welch AJ. A review of the optical properties of biological tissues. IEEE J Quantum Electronics 1990;26:2166-2185.
50. Hastings JW. Chemistries and colors of bioluminescent reactions: a review. Gene 1996;173:5-11.
51. Wilson T, Hastings JW. Bioluminescence, Annu Rev Cell Dev Biol 1998;14:197-230.
52. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt 2001;6:432-440.
53. Liu H, Iacono RP, Szalay AA. Detection of GDNF secretion in glial cell culture and from transformed cell implants in the brains of live animals. Mol Genet Genomics 2001;266:614-623.
54. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 2002;62:1862-1867.
55. Wetterwald A. van der Pluijm G, Que I. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 2002;160:1143-1153.
56. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 1995;18:593-603.
57. Greer III LF, Szalay AA. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 2002;17:43-74.
58. Honigman A, Zeira E, Ohana P. et al. Imaging transgene expression in live animals. Mol Ther 2001;4:239-249.
59. Farquhar TH, Chatziioannouand HA, Cherry SR. An evaluation of exact and approximate 3-D reconstruction algorithms for a high-resolution, small-animal PET scanner. IEEE Trans Med Imaging 1998;17:1073-1080.
60. Gambhir SS, Barrio JR, Wu L, et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 1998;39:2003-2011.
61. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998;58:4333-4341.
62. Wu JC, Sundaresan G, Iyer M, Gambhir SS, et al. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 2001;4:297-306.
63. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-17.
64. Macleod KF, Jacks T. Insights into cancer from transgenic mouse models. J Pathol 1999;187:43-60.
65. Van Dyke T, Jacks T. Cancer modeling in the modem era: progress and challenges. Cell 2002;108:135-144.
66. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 2001;29:1353-1360.
67. Costa GL, Sandora MR, Nakajima A, et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 2001;167:2379-2387.
68. Nakajima A, Seroogy CM, Sandora MR, et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001;107:1293-1301.
69. Frawley LS, Faught WJ, Nicholson J, Moomaw B. Real time measurement of gene expression in living endocrine cells. Endocrinology 1994;135:468-471.
70. Hooper CE, Ansorge RE, Browne HM, Tomkins P. CCD imaging of luciferase gene expression in single mammalian cells. J Biolumin Chemilumin 1990;5:123-130.
71. Hooper CE, Ansorge RE, Rushbrooke JG. Low-light imaging technology in the life sciences. J Biolumin Chemilumin 1994;9:113-122.
72. Thompson EM, Adenot P, Tsuji FI, Renard JP. Real time imaging of transcriptional activity in live mouse preimplantation embryos using a secreted luciferase. Proc Natl Acad Sci U S A 1995;92:1317-1321.
73. White MR, Masuko M, Amet L, et al. Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci 1995;108:441-455.
74. White MR, Wood CD, Millar CD. Real-time imaging of transcription in living cells and tissues. Biochem Soc Trans 1996;24;411S.
75. Millar AJ, Short SR, Chua NH, Kay SA. A novel circadian phenotype based on firefly luciferase expression in transgenic plants. Plant Cell 1992;4:1075-1087.
76. Millar AJ, Carre IA, Strayer CA, Chua NH, Kay SA. Circadian clock mutants in Arabidopsis identified by luciferase imaging. Science 1995;267:1161-1163.
77. Branchini BR, Magyar RA, Murtiasha MH, Anderson SM, Helgerson LC, Zimmer M. Site-directed mutagenesis of firefly luciferase active site amino acids: a proposed model for bioluminescence color. Biochemistry 1999;38:13223-13230.
78. Kajiyama N, Nakano E. Isolation and characterization of mutants of firefly luciferase which produce different colors of light. Protein Eng 1991;4:691-693.
79. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci U S A 2002:99;377-382.
80. Day RN, Kawecki M, Berry D. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques 1998;25:848-850, 852-854, 856.
81. Liu J, Wang Y, Szalay AA, Escher A. Visualizing and quantifying protein secretion using a Renilla luciferase-GFP fusion protein, Luminescence 2000;15:45-49.
82. Wang Y, Wang G, O'Kane DJ, Szalay AA. A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP. Mol Gen Genet 2001;256:578-587.
83. Ray P, Pimenta H, Paulmurugan R, et al. Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A 2002;99:3105-3110.
84. Clarke ND. A proposed mechanism for the self-splicing of proteins. Proc Natl Acad Sci U S A 1994;91:11084-11088.
85. Colston MJ, Davis EO. The ins and outs of protein splicing elements. Mol Microbiol 1994;12:359-363.
86. Pietrokovski S. Conserved sequence features of inteins (protein introns) and their use in identifying new inteins and related proteins. Protein Sci 1994;3:2340-2350.
87. Ozawa T, Kaihara A, Sato M, Tachihara K, Umezawa Y. Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing. Anal Chem 2001;11:2516-2521.
88. Baldwin TO. Firefly luciferase: the structure is known, but the mystery remains. Structure 1996;4;223-228.
89. Conti E, Franks NP, Brick P. Crystal structure of firefly luciferase throws light on a superfamily of adenylate-forming enzymes. Structure 1996;4:287-298.
90. Sandalova TP, Ugarova NN. Model of the active site of firefly luciferase. Biochemistry (Mosc) 1999;64:962-967.
91. Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A 2001;98:14595-14600.
92. Zhang L, Adams JY, Billick E, et al. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther 2002;5:223-232.